Clinical Follow-Up & Troubleshooting: Optimizing Outcomes in AID

July 21, 2026 1:00 PM - July 21, 2026 2:00 PM
This live webinar teaches clinicians how to structure follow-up, troubleshoot challenges, and optimize automated insulin delivery (AID) therapy for sustained, real‑world success.

CE Credit: 1.0
 
  • Description
  • Registration Information
  • Faculty
  • Disclosures
  • Accreditation
  • Technical Requirements
  • Credits

Event Date: Tuesday, July 21, 2026    
Event Time: 1:00 - 2:00 pm ET            
Please Note: All times are Eastern. This webinar begins at 1:00 pm Eastern / 12:00 pm Central / 11:00 am Mountain / 10:00 am Pacific.

Description

This webinar equips clinicians with the strategies and confidence needed to support long-term success with automated insulin delivery (AID). This session outlines a structured approach to early and ongoing follow-up, highlighting what to assess, when to intervene, and how to proactively address both technical and clinical challenges that can arise over time. Faculty will demonstrate how to interpret AID data to inform therapy adjustments and guide meaningful clinical decision-making, while also addressing how to support patients through life transitions that may impact AID use. Participants will gain practical troubleshooting techniques, clear escalation pathways for complex cases, and a follow-up framework designed to improve outcomes and sustain engagement, enhancing confidence in managing AID therapy in real-world practice.

This webinar is the fifth in our seven-part AID series.          
•  Part 1: Automated Insulin Delivery 101: Core Concepts & Patient Selection       
•  Part 2: Getting to Know the AID Landscape: Current & Future Options        
•  Part 3: Prescribing AID: Documentation, Workflow, and Team Roles         
•  Part 4: Patient Training & Onboarding for AID Systems - Laying the Groundwork for Success         
•  Part 5 (July 21): Clinical Follow-Up & Troubleshooting: Optimizing Outcomes in AID         
•  Part 6 (September 24): Case Studies in AID: Real-World Scenarios         
•  Part 7 (October TBD): Access & Affordability: Ensuring Equity in AID Therapy

Learning Outcome

Following this activity, ≥70% of participants will report increased confidence in troubleshooting AID-related issues, ≥65% will report increased comfort interpreting AID data for therapy adjustments, and participants will express intent to implement structured follow-up approaches in clinical practice.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify best practices for clinical follow-up after AID initiation.
  • Recognize common technical and clinical challenges associated with AID use.
  • Apply data-driven approaches to optimize AID therapy over time.
Activity Type

This is a knowledge-based learning activity.

Learning Format

Live Activity

Intended Audience

This activity is designed for diabetes care and education specialists, including nurses, dietitians, pharmacists, pharmacy technicians, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.

Support

This activity is supported by an unrestricted educational grant provided by Insulet Inc.

Pricing

This webinar is FREE to ADCES members and non-members.

Live webinar registration does not include access to the recorded webinar. The recorded webinar will be available separately within 2 weeks of the live broadcast on danatech: adces.org/danatech.

Accessing the Webinar

ADCES live webinars are hosted via Zoom. After registering, you will receive a confirmation email containing a Zoom link to join the webinar. If you do not receive the email, check your Spam or Junk folder. If you still do not see the email, please contact education@adces.org or call 800-338-3633, option 3.

Rebroadcasting, redistribution, and resale are prohibited.

Speaker

Natalie J. Bellini, DNP, FNP-BC, BC-ADM, CDCES  
Assistant Professor of Medicine 
Case Western Reserve University 
Program Director Diabetes Technology 
University Hospitals Diabetes and Metabolic Care Center

Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES is a Clinical Assistant Professor of Medicine at Case Western Reserve University and Endocrine Nurse Practitioner at University Hospitals in Cleveland, Ohio where she is the Program Director of Diabetes Technology following approximately sixty-five thousand people with diabetes. Dr. Bellini earned her bachelor’s degree in nursing from Drexel University and Family Nurse Practitioner and Doctor of Nursing Practice from D’Youville University. Dr. Bellini holds board certifications as a family nurse practitioner and in advanced diabetes management. She has published studies on topics including the use of GLP-1 agonists in patients with Type 1 diabetes as well as the use of technology in diabetes management. She has been a speaker nationally and internationally regarding diabetes management and the impact of technology on diabetes care and outcomes. She is currently serving as the chair of the Youth Advisory Committee for the ADA, served on the ADA Scientific Sessions Technology Planning Committee for 2024 and 2025. 

Natalie co-hosts podcast Diabetes Dialogue: Technology, Therapeutics, & Real Word Perspectives with colleague Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, through HCPLive at https://www.hcplive.com/clinical/endocrinology.

Faculty Disclosures

In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.

Joint Accreditation/ACCME also requires that ADCES mitigate any reported conflict and eliminate the potential for bias during the educational activity. The disclosure information is intended to identify any ineligible relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.

Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:

Speaker

Natalie J. Bellini, DNP, FNP-BC, BC-ADM, CDCES - Speaker: Abbott, Lilly, MannKind, Medtronic, Sanofi, Sequel

Planners

Dana Moreau – No relevant financial relationships          
LaurieAnn Scher, MS, RD, CDCES, FADCES – Consultant: GlucoSense, HousecallVR

Peer Reviewers

Eileen Egan DNP, FNP, CDCES, BC-ADM, FADCES – No relevant financial relationships
Charles D. Ponte, BS Pharm, PharmD, BC-ADM, CDCES – No relevant financial relationships
Julianne Steiner, MS, RDN, CDCES – No relevant financial relationships
Christine Zaveson, RN, MSN, PHN, CDCES – No relevant financial relationships
Bau Tran, PA-C, PharmD – No relevant financial relationships
Jocelyn Protopappas, MSW, MPH, RDN – No relevant financial relationships
Cassandra Henderson, MD, MSc, CDCES – No relevant financial relationships

All relevant financial relationships have been mitigated.

The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Financial Support

This activity is supported by an unrestricted educational grant provided by Insulet Inc.

Accreditation Information
In support of improving patient care, the Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 

Accreditation Council for Pharmacy Education (ACPE)

The Universal Activity Number is JA4008258-0000-26-280-L01-P, JA4008258-0000-26-280-L01-T. This knowledge-based activity has been approved for 1.0 contact hour(s).           
This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.

 

American Medical Association (AMA)

Association of Diabetes Care & Education Specialists designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

American Nurses Credentialing Center (ANCC)

Association of Diabetes Care & Education Specialists designates this activity for a maximum of 1.0 ANCC contact hour(s). This activity discusses 1.0 contact hour(s) of pharmacotherapeutic content.            
The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 1.0 contact hour(s).

American Academy of PAs (AAPA)

The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit(s). PAs should only claim credit commensurate with the extent of their participation.

Commission on Dietetic Registration (CDR)

CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education unit(s) (CPEU) for completion of this activity.            
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.

Association of Social Work Boards (ASWB) 

As a Jointly Accredited Organization, the Association of Diabetes Care & Education Specialists is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. The Association of Diabetes Care & Education Specialists maintains responsibility for this course. Social workers completing this course receive 1.0 continuing education credits.

Successful Completion

To receive a Statement of Credit you must participate in the full activity and complete an evaluation.

Certified Diabetes Care and Education Specialists

To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.

Board Certified Advanced Diabetes Management (BC-ADM)

CBDCE is the administering body for the Advanced Diabetes Management credentials. Continuing education programs offered by ADCES can be used toward fulfilling BC-ADM Certification and recertification requirements.

Other Health Professionals

It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.

Test Your Computer

To ensure that your participation is successful, please test your system as soon as possible so if you do have technical challenges, you will have time to get them sorted out. Click here to test your computer.

System Requirements

You must have a broadband wired or wireless (3G or 4G/LTE) internet connection to attend this event. Click here for operating system requirements.

Knowledge 1.00

Association of Diabetes Care & Education Specialists

Contact Us